Literature DB >> 28884562

ÖMPSQ-Short Score and determinants of chronic pain: cross-sectional results from a middle-aged birth cohort.

Olli Ruokolainen1,2, Juha Auvinen3,4,5, Steven J Linton6, Sauli Herrala3, Pasi Eskola3, Markus Paananen4, Raija Korpelainen3,4,7, Jaro Karppinen3,4,8.   

Abstract

BACKGROUND: The Örebro Musculoskeletal Pain Screening Questionnaire (ÖMPSQ) was developed to identify patients at risk of developing work disability due to pain. So far, neither the ÖMPSQ or its short version (ÖMSPQ-short) have been tested in population-based samples. AIM: We examined the associations between several well-known determinants for chronic pain and ÖMPSQ-Short Score.
DESIGN: Cross-sectional study.
SETTING: All measurements and tests were made at the University of Oulu. POPULATION: Subjects belonging to the Northern Finland Birth Cohort 1966 answered a questionnaire at the age of 46 years (N.=5637).
METHODS: The questionnaire included the ÖMPSQ-short as well as questions about smoking, education, location, number of pain sites, and physical activity. In addition, body weight and height were measured in order to calculate the Body Mass Index.
RESULTS: In multivariate logistic regression analysis, reporting 4-5 pain sites (females OR 3.4; males 3.0), ≥6 pain sites (females OR 12.4; males 7.4) and current smoking (females 1.8; males 2.6) were associated with being classified into the ÖMPSQ high risk group. In females, also obesity (OR 1.6) and less than 9 years of education (2.7) were associated with higher ÖMPSQ Score. The frequency of physical activity was not associated with the ÖMPSQ Score.
CONCLUSIONS: High number of pain sites and smoking among both genders, and obesity and low education level among females is associated with higher ÖMPSQ scores. Therefore, the ÖMPSQ-short may be a working instrument for also screening the general population. CLINICAL REHABILITATION IMPACT: Results of this study may improve the detection of patients at high risk of developing work disability due to pain.

Entities:  

Mesh:

Year:  2017        PMID: 28884562     DOI: 10.23736/S1973-9087.17.04439-2

Source DB:  PubMed          Journal:  Eur J Phys Rehabil Med        ISSN: 1973-9087            Impact factor:   2.874


  6 in total

Review 1.  Chronic pain: a review of its epidemiology and associated factors in population-based studies.

Authors:  Sarah E E Mills; Karen P Nicolson; Blair H Smith
Journal:  Br J Anaesth       Date:  2019-05-10       Impact factor: 9.166

2.  The effect of pain management group on chronic pain and pain related co-morbidities and symptoms. A stepped-wedge cluster randomized controlled trial. A study protocol.

Authors:  Marjatta Reilimo; Leena Kaila-Kangas; Rahman Shiri; Marjukka Laurola; Helena Miranda
Journal:  Contemp Clin Trials Commun       Date:  2020-06-27

3.  The effect of pain management group on chronic pain and pain related co-morbidities and symptoms. A stepped-wedge cluster randomized controlled trial. A study protocol.

Authors:  Marjatta Reilimo; Leena Kaila-Kangas; Rahman Shiri; Marjukka Laurola; Helena Miranda
Journal:  Contemp Clin Trials Commun       Date:  2020-06-18

4.  Psychometric Properties of the OSPRO-YF Screening Tool in Patients with Shoulder Pathology.

Authors:  Helen Razmjou; Veronica Palinkas; Susan Robarts; Deborah Kennedy
Journal:  Physiother Can       Date:  2021       Impact factor: 1.037

5.  Association of STarT Back Tool and the short form of the Örebro Musculoskeletal Pain Screening Questionnaire with multidimensional risk factors.

Authors:  Anna Sofia Simula; Olli Ruokolainen; Petteri Oura; Mikko Lausmaa; Riikka Holopainen; Maija Paukkunen; Juha Auvinen; Steven J Linton; Jonathan C Hill; Jaro Karppinen
Journal:  Sci Rep       Date:  2020-01-14       Impact factor: 4.379

6.  Determinants of Pain-Induced Disability in German Women with Endometriosis during the COVID-19 Pandemic.

Authors:  Roxana Schwab; Kathrin Stewen; Tanja Kottmann; Susanne Theis; Tania Elger; Bashar Haj Hamoud; Mona W Schmidt; Katharina Anic; Walburgis Brenner; Annette Hasenburg
Journal:  Int J Environ Res Public Health       Date:  2022-07-06       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.